Login
Toggle navigation
Videos
Categories
Trending
Sienna Cancer Diagnostics (ASX:SDX) update - Matthew Hoskin, CEO, Sienna Cancer Diagnostics Ltd
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Sienna Cancer Diagnostics, CEO, Matthew Hoskin provides an update
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Biogen CEO on Revolutionizing Drug Development for Rare Diseases with n-Lorem | CHRISTOPHER A. VIEHBACHER, PRESIDENT AND CHIEF EXECUTIVE OFFICER OF BIOGEN
00:10:00
Navigating a New World: Insights from Goldman Sachs, Ruffer LLP, and Principal Asset Management
00:10:00
Is Your Business Prepared? TXT e-Solutions Announces Readiness for SQL Server 2012 | Riccardo Proni , CTO AT TXT e solutions Sp
00:10:00
"Leadership, for me, is about relationships. Understand the need of the person you're dealing with and find a way to fill it, fostering mutual respect and trust."|Jean-Louis Servranckx is President and Chief Executive Officer of Aecon Group Inc.
00:10:00
We help ambitious founders who actively seek to change the status|David Fialkow,Managing Director,General Catalyst
00:10:00
Queensland Students Engage in Peatland Restoration with Australian Government Support
00:10:00
Innovations in Investment Strategy: PFM Asset Management LLC Presentation on March 27, 2023
00:10:00
Journey of a Trailblazer: Gene's Path from Administrative Assistant to CEO of Wellington | Jean Hynes , CEO , Wellington Management.
00:00:00
ReNeuron Group's phase IIb stroke trial kicks off with first patient treated - Michael Hunt, Chief Financial Officer, ReNeuron Group
00:10:00
Italian-French Collaboration in Energy Transition: A Crucial Step Towards Sustainable and Economically Viable Solutions | Nicola Monti, CEO, Edison SpA
00:10:00
A revolutionary antibody approach for fighting cancer|James Campbell,Managing Director,Patrys Ltd
00:10:00
Aarhus Physics APS: Advancing Geophysical Consulting with Airborne Electromagnetic Technology